Concepedia

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

Alenka Mavri, Marie‐Christine Alessi, O. Geel-Georgelin, F. Fina, Jožica T. Sentočnik, Delphine Bastelica, Mojca Stegnar, I. Juhan‐Vague

Diabetologia · 2001 · 120 citations · 23 references

DOIFull text

Open access

Concepts

References

23

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Anders Hamsten, Göran Walldius, Alfred Szamosi et al. · The Lancet · 1987 · 1.5K citations

, , +11

Fibrinolytic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients With Angina Pectoris

Stephen Pyke, Marie‐Christine Alessi, Jørgen Jespersen et al. · Circulation · 1996 · 552 citations

, , +15

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

P Vague, I. Juhan‐Vague, Marie Françoise Aillaud et al. · Metabolism · 1986 · 448 citations

, , +9

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1

Kerstin Landin‐Wilhelmsen, Lennart Stigendal, E. Eriksson et al. · Metabolism · 1990 · 343 citations

, , +10

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

Marie‐Christine Alessi, Delphine Bastelica, Pierre‐Emmanuel Morange et al. · Diabetes · 2000 · 341 citations · Full text

, , +16